Ir al contenido

Últimas cifras

Cobertura de la terapia antirretroviral para la prevención de la transmisión de madre a hijo

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).

Último dato, 202382%of pregnant women living with HIVPublicación anual · Sin actualizar
vs 2022+1.0 p. p.81%
Máximo desde 200082% of pregnant women living with HIV2023 · Banco Mundial
Mínimo desde 20002% of pregnant women living with HIV2000 · Banco Mundial

Evolución

2013 - 2023

Últimos años

  1. 202382% of pregnant women living with HIV+1.0 p. p.
  2. 202281% of pregnant women living with HIV+9.0 p. p.
  3. 202172% of pregnant women living with HIV+7.0 p. p.
  4. 202065% of pregnant women living with HIV+1.0 p. p.
  5. 201964% of pregnant women living with HIVSin cambio
  6. 201864% of pregnant women living with HIV+12.0 p. p.
  7. 201752% of pregnant women living with HIV+3.0 p. p.
  8. 201649% of pregnant women living with HIV+11.0 p. p.
Tabla completa
PeriodoValor
202382% of pregnant women living with HIV
202281% of pregnant women living with HIV
202172% of pregnant women living with HIV
202065% of pregnant women living with HIV
201964% of pregnant women living with HIV
201864% of pregnant women living with HIV
201752% of pregnant women living with HIV
201649% of pregnant women living with HIV
201538% of pregnant women living with HIV
201461% of pregnant women living with HIV
201369% of pregnant women living with HIV
201243% of pregnant women living with HIV
201159% of pregnant women living with HIV
201044% of pregnant women living with HIV
200965% of pregnant women living with HIV
200846% of pregnant women living with HIV
200751% of pregnant women living with HIV
200654% of pregnant women living with HIV
20056% of pregnant women living with HIV
20044% of pregnant women living with HIV
20033% of pregnant women living with HIV
20024% of pregnant women living with HIV
20013% of pregnant women living with HIV
20002% of pregnant women living with HIV